Google DeepMind’s Demis Hassabis on his Nobel Prize: ‘It feels like a watershed moment for AI’ The founder of the artificial intelligence R&D lab says scientific understanding can prevent ...

After Geoffrey Hinton won the 2024 Nobel Prize for Physics, Demis Hassabis and John Jumper have been awarded the Nobel in Chemistry, and they all have Google in common.

Alphabet's AI drug development subsidiary Isomorphic Labs is aiming to initiate clinical trials for its AI-developed oncology ...

Google DeepMind won bragging rights that its competitors in the field of AI could only dream of. A share of the 2024 Nobel Prize in Chemistry was awarded to Demis Hassabis, its CEO, and John Jumper, ...

Searches on Apple devices are falling for the first time ever as more and more young people are turning to smart chatbots ...

Research is first initiative from Big Tech group’s AI health unit formed by ex-DeepMind co-founder Mustafa Suleyman ...

Google DeepMind has launched a new AI model called AlphaGenome. The new tool will aim to predict how genetic mutations impact our health and may even potential provide new treatments.

Google DeepMind's drug discovery company, Isomorphic Labs, is gearing up to launch the human trials of its AI-designed drugs.

Alphabet’s Isomorphic Labs is preparing to begin human trials of a drug designed using AI, based on protein modelling ...

The EU AI Champions Initiative is a group of about 70 financial, technology, and industrial companies that is not an ...

AI’s advantage over humans comes down to 4 dimensions: speed, scale, scope and sophistication. Whether AI can replace you depends on how much one or more of the S’s matter in what you do.